Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning

@article{Davids2001StereoselectiveEO,
  title={Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning},
  author={Eugen Davids and Kehong Zhang and Frank I. Tarazi and Ross J. Baldessarini},
  journal={Psychopharmacology},
  year={2001},
  volume={160},
  pages={92-98}
}
Abstract.Rationale: The psychostimulant dl-threo-methylphenidate is commonly used to treat attention deficit-hyperactivity disorder (ADHD). Consistent with its effects in ADHD patients, racemic methylphenidate antagonizes behavioral hyperactivity in several animal models of ADHD, including juvenile rats with neonatal 6-hydroxydopamine (6-OHDA) lesions of forebrain dopamine projections. The enantiomers of methylphenidate differ markedly in stimulant potency but have not been compared in the 6… 

Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.

The findings indicate that behavioral effects of stimulants in young rats with neonatal 6-OHDA lesions may be mediated by release of NE or 5-HT and support interest in using drugs that increase activity of norepinephrine or serotonin to treat ADHD.

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.

We recently reported that selective inhibitors of neuronal transport of norepinephrine (NE), desipramine and nisoxetine, reversed motor hyperactivity in an animal model of attention-deficit

The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro

Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model

Investigation of dopamine transporter (DAT) density and behavioral outcomes in BrdU‐rats revealed no significant changes in striatal DAT densities, although adult animals displayed hyperactive behavior in a mildly stressful environment as well as hypersensitivity to a psychostimulant that facilitates dopaminergic neurotransmission.

Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic–pharmacodynamic relationships

Sarizotan may have potential anti-ADHD effects at low doses free of the previously reported side-effects and a classical pharmacokinetic–pharmacodynamic relationship based on free brain concentrations seems to be less appropriate than target engagement pharmacodynamic readouts.

Behavioral responses to methylphenidate and apomorphine in rats exposed neonatally to bisphenol-A.

Though some behavioral changes are evident in rats at an early stage (4-5 weeks) after neonatal treatment with bisphenol-A, the pretreatment does not induce any behavioral changes in habituation to a novel environment or in response to methylphenidate and to apomorphine at a later stage (8-10 weeks).
...

References

SHOWING 1-10 OF 46 REFERENCES

Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance.

Methylphenidate had no effect on T-maze performance in normals, but significantly improved performance in 6-hydroxydopamine-treated animals, suggesting that the "paradoxical" response to methylphenidate found in 7-day-old rat pups may be the result of central denervation supersensitivity.

Proposed animal model of attention deficit hyperactivity disorder

Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats

Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain

There is direct evidence that oral methylphenidate at doses within the therapeutic range significantly increases extracellular DA in human brain, and this result coupled with recent findings of increased dopamine transporters in ADHD patients provides a mechanistic framework for the therapeutic efficacy of methyl phenidate.

Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pups.

A role of brain DA in learning inlearning in young rats is indicated and Amphetamine treatment before conditioning produced an improvement in performance in animals previously treated with 6-OHDA/DMI, but it impaired performance in controls, regardless of the time of injection.

The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups

Neonatal 6-hydroxydopamine-induced dopamine depletions: Motor activity and performance in maze learning

Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder.

The purpose of this present investigation was to determine whether the levels of methylphenidate were sustained for over a time period of 8 h, and to examine enantioselective aspects of the pharmacokinetics following the ingestion of the sustained-release formulation.